STOCK TITAN

Silexion Therapeutics Warrant (SLXNW) Stock Price, News & Analysis

SLXNW NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
118 188 sessions, October 21, 2025 to October 21, 2026
Largest daily move
+98.8% close of July 17, 2026
1-year change
-84.5% closing prices, October 21, 2025 to October 21, 2026
1-month change
-21.1% closing prices, September 21, 2026 to October 21, 2026

Company Description

Silexion Therapeutics Warrant (NASDAQ: SLXNW) is classified in the biological products, (no diagnostic substances) industry.

SLXNW has declined 84.5% over the past year. The last closing price was $0.0060.

For FY2025, Silexion Therapeutics Warrant reported revenue of $155K with net income of -$11.9M and diluted earnings per share of $89.61.

This page collects what Stock Titan holds for SLXNW, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$0.0148
+146.67%
+0.01
Last updated: October 22, 2026 at 13:43
-84.5%
Performance 1 year

Silexion Therapeutics Warrant (SLXNW) closed at $0.0060 on October 21, 2026. Over the past 12 months, the price has lost 84.5%.

See what a $1,000 investment in SLXNW would be worth today

Average down calculator for SLXNW

SLXNW Metrics & Rankings

Month to date
+17.6%
View ranking
YTD
-76.9%
View ranking

Price returns through October 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for SLXNW.

Financial Highlights

Silexion Therapeutics Warrant generated $155K in revenue in FY2025, operating income reached -$11.6M, and net income was -$11.9M. Diluted earnings per share stood at $89.61. The company generated -$10.8M in operating cash flow. The current ratio was 2.41, measuring current assets divided by current liabilities.

$155K
Revenue (FY2025)
-$11.9M
Net Income (FY2025)
-$10.8M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Silexion Therapeutics Warrant (SLXNW) currently stands at 81.3 thousand shares, up 2.3% from the previous reporting period. Since October 2025, short interest has increased by 1453.3%.

Days to Cover History

Last 12 Months

Days to cover for Silexion Therapeutics Warrant (SLXNW) currently stands at 5.6 days, down 72.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 463%. Across the settlements charted above, it has ranged from 1.0 to 20.7 days.

SLXNW Company Profile & Sector Positioning

Silexion Therapeutics Warrant (SLXNW) and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Silexion Therapeutics Warrant (SLXNW)?

The current stock price of Silexion Therapeutics Warrant (SLXNW) is $0.0148 as of October 22, 2026.

What is the revenue of Silexion Therapeutics Warrant (SLXNW) stock?

The FY2025 revenue of Silexion Therapeutics Warrant (SLXNW) is $155K, from its most recent completed fiscal year.

What is the net income of Silexion Therapeutics Warrant (SLXNW)?

The FY2025 net income of Silexion Therapeutics Warrant (SLXNW) is -$11.9M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Silexion Therapeutics Warrant (SLXNW)?

The diluted earnings per share (EPS) of Silexion Therapeutics Warrant (SLXNW) is $89.61 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Silexion Therapeutics Warrant (SLXNW)?

The operating cash flow of Silexion Therapeutics Warrant (SLXNW) is -$10.8M for FY2025, its most recent completed fiscal year. Learn about cash flow.

What is the current ratio of Silexion Therapeutics Warrant (SLXNW)?

The current ratio of Silexion Therapeutics Warrant (SLXNW), current assets divided by current liabilities, was 2.41 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

What is the operating income of Silexion Therapeutics Warrant (SLXNW)?

The operating income of Silexion Therapeutics Warrant (SLXNW) is -$11.6M for FY2025, its most recent completed fiscal year. Learn about operating income.